all.health
all.health is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at all.health.
all.health is a company.
Key people at all.health.
Key people at all.health.
all.health is a health tech company building the all.health ICM™ (Integrated Continuous Management) platform, an FDA-recognized system that collects and analyzes 24/7 vital and biometric data from consumer wearables to detect lifestyle diseases early and manage existing conditions.[5] It serves patients seeking proactive health monitoring and providers/health systems aiming to integrate continuous remote care into workflows, solving the problem of fragmented healthcare by enabling daily health insights over single snapshots, reducing unnecessary visits, and improving outcomes through AI-driven, evidence-based guidance.[5]
The platform bridges patients and care teams with clinical-grade tech, fostering personalized, predictive care while addressing access barriers like distance, cost, and physical limitations. Growth momentum stems from partnerships with health systems, emphasis on provider-centric design, and scalability for continuous monitoring, positioning it as a tool for proactive healthcare transformation.[5]
Specific details on all.health's founding year, founders, or early traction are not available in current sources, limiting a full backstory. The company emerged in the remote patient monitoring space, likely driven by the need for continuous data amid rising chronic disease prevalence and wearable tech adoption, as evidenced by its focus on integrating consumer devices with clinical workflows.[5] Pivotal moments include FDA recognition for its AI models and system, enabling real-world deployment for disease screening and management, with an emphasis on provider collaboration from inception to ensure clinical relevance.[5]
all.health rides the remote patient monitoring (RPM) and digital health trend, accelerated by post-pandemic demand for virtual care, wearable proliferation (e.g., Apple Watch, Fitbit), and chronic disease burdens like diabetes and heart conditions affecting millions.[5] Timing is ideal amid regulatory support for FDA-cleared AI in health tech and payer incentives for outcome-based models, with market forces like aging populations and healthcare cost pressures favoring scalable, data-driven solutions over traditional visits.[5]
It influences the ecosystem by empowering providers with continuous insights, potentially reducing U.S. healthcare spend (projected at $4.5T+ annually) through prevention, while standardizing wearable data for clinical use and fostering hybrid care models.[5]
all.health is poised to expand via deeper health system integrations and AI enhancements for broader disease screening, capitalizing on RPM market growth (expected to hit $50B+ by 2028). Trends like multimodal data (wearables + genomics) and value-based care will shape its path, evolving its influence toward ecosystem-wide standards for continuous health management. This positions it as a key player in shifting healthcare from reactive to predictive, delivering the peace of mind promised in its core mission.[5]
